TIME BIO MANAGEMENT, LLC
TIME BIO MANAGEMENT, LLC is a Pre-seed, Seed and Series A fund in the US investing in therapeutics, diagnostics, research-tools, medical-devices, care-delivery and healthcare-tech.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- therapeutics, diagnostics, research-tools, medical-devices, care-delivery, healthcare-tech
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $136M
- Website
- timebioventures.com
Check size not disclosed
Thesis
Time BioVentures is an early-stage venture capital firm founded in 2020 and based in Los Angeles, California. The firm operates under the legal name TIME BIO MANAGEMENT, LLC and focuses on the life sciences and healthcare sectors, with a particular emphasis on therapeutics, diagnostics, research tools, medical devices, and care delivery. Their investment thesis centers on financing entrepreneurs developing transformative medical products and technologies that can significantly improve patient outcomes and longevity. Time BioVentures primarily targets early-stage companies, specifically in the pre-seed, seed, seed-plus, and Series A funding rounds, and seeks out "iconoclastic founders" aiming to create radically better solutions for the healthcare system. The firm's geographic scope is primarily North America. Time BioVentures announced the close of its first fund, Time BioVentures I, LP, in October 2022, with $100 million in AUM, and as of March 31, 2026, reported $136,692,060 in private fund assets under management. The firm prefers warm introductions for pitches and can be contacted via their website.
Common questions
Does TIME BIO MANAGEMENT, LLC invest at the Pre-seed stage?
Yes. TIME BIO MANAGEMENT, LLC lists Pre-seed, Seed and Series A among the stages it invests in.
Where does TIME BIO MANAGEMENT, LLC invest?
TIME BIO MANAGEMENT, LLC invests in the US.